, Organisation Mondiale de la Santé. Les 10 principales causes de mortalité
,
Traiter l'hypercholestérolémie seule n'est pas suffisant dans la prise en charge du risque cardiovasculaire ,
, Données annuelles sur les médicaments remboursés par l'Assurance Maladie. Medic'AM 2017
Usage des Statines ,
, Rapport sur les conditions de retrait du marché des spécialités contenant de la cérivastatine (Staltor® & Cholstat®) le 08 août 2001 et obligations de pharmacovigilance
, bis : Dyslipidémies. Universités médicales francophines, vol.129, p.129
, Étude Nationale Nutrition Santé ENNS, 2006.
,
Maladies cardio-neuro-vasculaires ,
,
Les maladies cardiovasculaires ,
, Organisation Mondiale de la Santé
Trends in the epidemiology of cardiovascular disease in the UK. Heart, vol.102, pp.1945-52, 2016. ,
, Public Health Agency of Canada. Chronic disease and injury indicator framework
,
Multinational MONItoring of trends and determinants in Cardiovascular disease -Registre des cardiopathies ischémiques de la Haute, 2011. ,
,
La fréquence des maladies cardio-vasculaires en France et en Europe. adsp, pp.20-22, 2004. ,
,
,
Histoire des statines. Médecine Mal Métaboliques, vol.7, pp.407-419, 2013. ,
, Analyse des ventes de médicaments aux officines et aux hôpitaux en France 11 ème édition
, Medic'AM 2017 tous régimes. Données mensuelles et annuelles sur les médicaments remboursés par l'Assurance Maladie
,
Traiter l'hypercholestérolémie seule n'est pas suffisant dans la prise en charge du risque cardiovasculaire ,
Comparison of Five Major Guidelines for Statin Use in Primary Prevention in a Contemporary General Population, Ann Intern Med, vol.168, issue.2, pp.85-92, 2018. ,
, Organisation Mondiale de la Santé
,
Définition de l'EDC selon le DSM-5 ,
,
Les troubles de l'humeur selon le DSM-5 : quelles conséquences prévisibles? La Lettre du Psychiatre, 2014. ,
Dépression de l'adulte -Repérage et prise en charge initiale ,
,
Episode dépressif caractérisé de l'adulte : prise en charge en soins de premier recours. Recommandations pour la pratique clinique ,
,
Troubles dépressifs récurrents ou persistants de l'adulte ,
Prise en charge de la dépression ,
Projections of global mortality and burden of disease from 2002 to 2030, PLoS Med, vol.3, issue.11, p.442, 2006. ,
) : prévalence, recours au soin et sentiment d'information de la population. La santé de l'homme, pp.43-48, 2005. ,
Données relatives aux patients nouvellement admis dans le dispositif des ALD une année donnée ,
,
Dépression de l'adulte -Repérage et prise en charge initiale ,
Evaluation et prise en charge des personnes âgées faisant des chutes répétées ,
Aged -MeSH -NCBI ,
World Health Organization. Health situation and trend assessment. Elderly population ,
Institut national de la statistique et des études économiques ,
Comprehensive assessment of comorbidity in the elderly. Geriatr Psychol Neuropsychiatr Vieil, vol.13, pp.7-12, 2015. ,
Épidémiologie des comorbidités chez les personnes âgées. NPG NeurolPsychiatr -Gériatrie, vol.7, pp.11-14, 2007. ,
, Bon usage des médicaments : antidépresseurs dans le traitement des troubles dépressifs et des troubles anxieux de l'adulte
) : prévalence, recours au soin et sentiment d'information de la population. La santé de l'homme, pp.43-48, 2005. ,
Article R1121-1 du Code de la Santé Publique ,
,
, Differences between clinical trials and postmarketing use -Martin -2004, 2018.
, Agence Nationale de Sécurité des Médicaments et des produits de santé. DUTASTERIDE BIOGARAN 0.5 mg, capsule molle -Résumé des caractéristiques du produit
,
Commission de la Transparence ,
Do cholesterol-lowering agents affect brain activity? A comparison of simvastatin, pravastatin, and placebo in healthy volunteers, Br J Clin Pharmacol, vol.37, issue.3, pp.231-237, 1994. ,
Lipophilic statin use and suicidal ideation in a sample of adults with mood disorders, Crisis, vol.35, issue.4, pp.278-82, 2014. ,
Interactions between pro-inflammatory cytokines and statins on depression in patients with acute coronary syndrome, Prog Neuropsychopharmacol Biol Psychiatry, vol.80, pp.250-254, 2018. ,
Do Statins Have Antidepressant Effects? CNS Drugs, vol.31, pp.335-378, 2017. ,
Association between C reactive protein level and depressive symptoms in an elderly Korean population: Korean Social Life, Health and Aging Project, BMJ Open, vol.5, issue.2, p.6429, 2015. ,
Depressive symptoms in hypercholesterolaemic patients treated with pravastatin. The Lancet, vol.340, p.910, 1992. ,
Depressive symptoms and cholesterol-lowering drugs. The Lancet, vol.341, p.114, 1993. ,
Statin use increases the risk of depressive disorder in stroke patients: A population-based study, J Neurol Sci, vol.348, issue.1-2, pp.89-93, 2015. ,
A prospective study of statin use and poststroke depression, J Clin Psychopharmacol, vol.34, issue.1, pp.72-81, 2014. ,
Statins use and risk of depression: a systematic review and meta-analysis, J Affect Disord, vol.160, pp.62-69, 2014. ,
In a randomized, double-blind clinical trial, adjuvant atorvastatin improved symptoms of depression and blood lipid values in patients suffering from severe major depressive disorder, J Psychiatr Res, vol.58, pp.109-123, 2014. ,
The use of statins for the treatment of depression in patients with acute coronary syndrome. Transl Psychiatry, vol.5, p.620, 2015. ,
Statins for the treatment of depression: A meta-analysis of randomized, double-blind, placebo-controlled trials, J Affect Disord, vol.200, pp.235-277, 2016. ,
Comparison of the Risk of Psychological and Cognitive Disorders Between Persistent and Nonpersistent Statin Users, Am J Cardiol, vol.114, issue.7, pp.1035-1044, 2014. ,
Serum cholesterol and depressive symptoms in elderly Finnish men, Int J Geriatr Psychiatry, vol.17, issue.7, pp.629-663, 2002. ,
The effects of statins on mood: a review of the literature, Eur J Cardiovasc Nurs, vol.11, issue.1, pp.85-96, 2012. ,
Randomised placebo controlled trial of effect on mood of lowering cholesterol concentration. Oxford Cholesterol Study Group, BMJ, vol.13, issue.7049, pp.75-83, 1996. ,
Lipid-lowering medication use and aggression scores in women: a report from the NHLBIsponsored WISE study, J Womens Health, vol.17, issue.2, pp.187-94, 2002. ,
Long-term assessment of psychological well-being in a randomized placebo-controlled trial of cholesterol reduction with pravastatin. The LIPID Study Investigators, Arch Intern Med, vol.160, issue.20, pp.3144-52, 2000. ,
Effects of lovastatin on cognitive function and psychological well-being, Am J Med, vol.108, issue.7, pp.538-584, 2000. ,
Effects of statin use on muscle strength, cognition, and depressive symptoms in older adults, J Am Geriatr Soc, vol.55, issue.3, pp.420-425, 2007. ,
Simvastatin causes changes in affective processes in elderly volunteers, J Am Geriatr Soc, vol.54, issue.1, pp.70-76, 2006. ,
Does simvastatin affect mood and steroid hormone levels in hypercholesterolemic men? A randomized double-blind trial, Psychoneuroendocrinology, vol.28, issue.2, pp.181-94, 2003. ,
Efficacité et effets indésirables des statines : évidences et polémiques ,
Portail de signalement des évènements sanitaires indésirables ,
What is Vigibase? ,
Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database, Br J Clin Pharmacol, vol.72, issue.6, pp.905-913, 2011. ,
The reporting odds ratio versus the proportional reporting ratio: "deuce, Pharmacoepidemiol Drug Saf, vol.13, issue.8, pp.527-528, 2004. ,
Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports, Pharmacoepidemiol Drug Saf, vol.10, issue.6, pp.483-489, 2001. ,
Is spontaneous reporting always the most important information supporting drug withdrawals for pharmacovigilance reasons in France? Pharmacoepidemiol Drug Saf, vol.21, pp.1289-94, 2012. ,
, Medical Dictionary for Regulatory Activities
Case-non case studies: Principles, methods, bias and interpretation, Therapie, vol.73, issue.3, pp.247-55, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01741153
A Method for the Minimization of Competition Bias in Signal Detection from Spontaneous Reporting Databases, Drug Saf, vol.39, issue.3, pp.251-60, 2016. ,
A potential eventcompetition bias in safety signal detection: results from a spontaneous reporting research database in France, Drug Saf, vol.36, issue.7, pp.565-72, 2013. ,
Statin use and risk of depression in patients with coronary heart disease: longitudinal data from the Heart and Soul Study, J Clin Psychiatry, vol.73, issue.5, pp.610-615, 2012. ,
, Agence Nationale de Sécurité du Médicament et des produits de santé, CRESTOR 20 mg
Améliorer la prescription des psychotropes chez les personnes âgées, Bilan d'étape, 2008. ,
Rates of spontaneous reporting of adverse drug reactions in France, JAMA, vol.288, issue.13, p.1588, 2002. ,
Irreversible atorvastatin-associated hearing loss, Pharmacotherapy, vol.32, issue.2, pp.27-34, 2012. ,
Performance of the standardised MedDRA® queries for case retrieval in the French spontaneous reporting database, Drug Saf, vol.37, issue.7, pp.537-579, 2014. ,
Dictionnaire de pharmaco-épidémiologie ,
,
Imputation of the unexpected or toxic effects of drugs. Actualization of the method used in France, Therapie, vol.40, issue.2, pp.111-119, 1985. ,
, Arrêté du 28 avril 2005 relatif aux bonnes pratiques de pharmacovigilance
,
Réactualisation de la méthode française d'imputabilité des effets indésirables des médicaments, Thérapie, vol.66, issue.6, pp.517-542, 2011. ,